Stock 300009 ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Anhui Anke Biotechnology (Group) Co., Ltd.

Equities

300009

CNE100000GY2

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
10.22 CNY +2.51% Intraday chart for Anhui Anke Biotechnology (Group) Co., Ltd. +2.92% -.--%
25/04 Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
27/03 Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Anhui Anke Biotechnology Co., Ltd. Proposes Final Dividend for 2023
CI
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Anke Biotechnology's Unit Passes US FDA Workplace Inspection
MT
Anhui Anke Biotechnology Co., Ltd. agreed to acquire 11.31% stake in Anhui Xinhuakun Biological Engineering Co., Ltd. from a group of shareholders for CNY 10.3 million.
CI
Anhui Anke Biotechnology Gets Nod to Market Breast Cancer Drug
MT
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Anhui Anke Biotechnology Co., Ltd. Declares Final Cash Dividend for 2022 on A Shares, Payable on 19 May 2023
CI
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Anhui Anke Biotechnology Co., Ltd. Approves Cash Dividend for 2022
CI
Anhui Anke Biotechnology Co., Ltd. Proposes Final Cash Dividend for the Year of 2022
CI
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Anhui Anke Biotechnology Co., Ltd. Announces Board Elections
CI
Anhui Anke Biotechnology Unit Gets Regulatory Nod For Anti-Postpartum Hemorrhage Drug
MT
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Tranche Update on Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2022.
CI
Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback announced on February 8, 2022, has expired with 4,187,406 shares, representing 0.26% for CNY 40.05 million.
CI
Tranche Update on Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2022.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300009 Stock
  4. News Anhui Anke Biotechnology (Group) Co., Ltd.